TSO3 Inc. reported unaudited consolidated earnings results for the fourth quarter and year ended December 31, 2017. For the quarter, the company’s revenues increased to $5.8 million, as compared to $5.1 million in the third quarter of 2017 and $3.7 million in the fourth quarter of 2016. The company's net loss was $1.4 million or $0.02 per share as compared to $1.8 million, or $0.02 per share, in the third quarter of 2017 and to $2.1 million or $0.02 per share in the year-ago quarter. Cash used by the operating activities was $0.7 million, as compared to $0.6 million in the third quarter of 2017. Adjusted EBITDA was $887,000 compared to $1,371,000 a year ago. Net loss before income taxes was $1,508,000 compared to $2,020,000 a year ago. Cash flows used in operating activities was $674,000 compared to $1,053,000 a year ago. Acquisition of property, plant and equipment was $513,000 compared to $450,000 a year ago. Acquisition of intangible assets was $50,000 compared to $66,000 a year ago. For the full year of 2017, the company’s revenue increased to $19.7 million in 2017, which included shipments of 170 STERIZONE VP4 Sterilizers and associated accessories and consumables to Getinge, as compared to $13.3 million in 2016. The company's net loss was $7.5 million or $0.08 per share, as compared to a net loss of $4.4 million or $0.05 per share in 2016, or a 2016 non-IFRS net loss of $5.7 million or $0.06 per share when excluding one-time items. Net loss before income taxes was $7,424,000 compared to $4,270,000 a year ago. Cash flows used in operating activities was $3,130,000 compared to $5,390,000 a year ago. Acquisition of property, plant and equipment was $1,567,000 compared to $1,085,000 a year ago. Acquisition of intangible assets was $239,000 compared to $314,000 a year ago.